MILLENNIUM MANAGEMENT LLC 13D and 13G filings for Aclaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-09 4:18 pm Sale | 2024-09-30 | 13G | Aclaris Therapeutics, Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,005,598 4.200% | -764,328 (-20.27%) | Filing |
| 2024-02-14 4:13 pm Purchase | 2024-02-05 | 13G | Aclaris Therapeutics, Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,769,926 5.300% | 290,565 (+8.35%) | Filing |
| 2024-02-01 4:15 pm Sale | 2023-12-31 | 13G | Aclaris Therapeutics, Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,479,361 4.900% | -108,753 (-3.03%) | Filing |
| 2023-12-11 4:25 pm Purchase | 2023-12-07 | 13G | Aclaris Therapeutics, Inc. ACRS | MILLENNIUM MANAGEMENT LLC | 3,588,114 5.100% | 3,588,114 (New Position) | Filing |